{"id":153296,"title":"Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T12:20:45.106000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/palivizumab-respiratory-syncitial-virus-infection-infants.html","snippet":"Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and…","rawSnapshotUrl":"/api/snapshots/raw/153296","browseUrl":"https://replay.healtharchive.ca/job-1/20250418122045/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/palivizumab-respiratory-syncitial-virus-infection-infants.html#ha_snapshot=153296","mimeType":"text/html","statusCode":200}